.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Study to assess merger of Epi-LASIK, wavefront

January 1, 2005

Duluth, GA-Norwood Abbey Ltd. has launched a 3-month study of postoperative comfort, visual recovery, and wavefront-guided custom ablation with its Centurion SES Epikeratome with EpiEdge for Epi-LASIK for the treatment of myopia.

Duluth, GA-Norwood Abbey Ltd. has launched a 3-month study of postoperative comfort, visual recovery, and wavefront-guided custom ablation with its Centurion SES Epikeratome with EpiEdge for Epi-LASIK for the treatment of myopia.

Marguerite B. McDonald, MD, FACS, will serve as principal investigator and medical monitor; Daniel S. Durrie, MD, and Lee Shahinian, MD, are clinical investigators.

The study will examine how combining Epi-LASIK and wavefront diagnostics would affect visual outcomes. Some 35 patients will be enrolled at each of three U.S. study sites.